The Best Ibogaine Documentaries: Films That Changed the Conversation

If you’ve searched for an ibogaine documentary before landing here, you already know the films exist — you’ve just had trouble figuring out which ones are worth your time, which ones are accurate, and where to actually watch them.

This guide covers the most significant films and media segments that have shaped public understanding of ibogaine, from its roots in West African Bwiti ceremony to its use as an addiction interruption tool in clinics across Mexico, Portugal, and beyond. Each entry notes what the film gets right, where it falls short, and what it means for someone actively considering treatment.

One thing to say upfront: documentaries are not a substitute for medical consultation. What you see on screen is almost always the best-case narrative. A real provider conversation will give you a far more complete picture. If you’d like that conversation, schedule a consultation here or call (866) 435-7057.

Why Ibogaine Gets Documented

Ibogaine is a Schedule I controlled substance in the United States, which means clinical trials are expensive and slow, and most treatment happens abroad — primarily in Mexico, Portugal, Costa Rica, and a handful of other countries. For decades, the primary way most Americans heard about ibogaine wasn’t through their doctor or a peer-reviewed paper. It was through a documentary.

That outsized influence is why the films matter. A single 90-minute documentary has, in documented cases, directly driven people toward (and occasionally away from) ibogaine treatment. Understanding the narrative each film is trying to tell helps you watch them more critically.

The Core Films

Ibogaine: Rite of Passage (2004)

Directed by Ben De Loenen and produced by ICEERS (the International Center for Ethnobotanical Education, Research, and Service), this is the foundational ibogaine documentary. It remains the most rigorously balanced film on the subject made to date.

De Loenen spent years in Gabon studying the Bwiti tradition, where iboga — the root bark from which ibogaine is extracted — has been used in initiation ceremonies for centuries among the Bwiti people of the Fang ethnic group. The film doesn’t treat Bwiti ceremony as a colorful backdrop for a Western addiction story. It gives it its own chapter.

The Dutch portion of the film follows patients at a clinic in the Netherlands, where ibogaine was legal at the time (it was never scheduled there until significantly later) and had been used clinically since the 1980s under the influence of Dutch pharmacologist Jan Bastiaans and, later, the work catalyzed by Howard Lotsof’s patents. Patients on camera include people with heroin addiction who had failed conventional treatment repeatedly.

What the film gets right: the dual nature of ibogaine — pharmacological tool and ceremonial sacrament — and the fact that these aren’t the same experience even when the molecule is the same. De Loenen doesn’t oversell outcomes.

What it doesn’t cover: the cardiac risk profile wasn’t fully understood in 2004. The deaths that would later be studied in systematic reviews hadn’t yet produced the safety protocols that good clinics use today.

Where to find it: ICEERS has made portions available online. Searching the title on Vimeo typically surfaces it.

Dosed (2019) and Dosed 2: The Trip of a Lifetime (2022)

Canadian filmmaker Tyler Chandler’s two-part documentary series is probably the most widely seen psychedelic-medicine film made in the last decade, partly because it’s well-produced and partly because it tracks a single subject — a woman named Adrianne — over an extended period.

The first film follows Adrianne’s use of psilocybin mushrooms and ibogaine to address heroin addiction and suicidality after years of failed treatment. The second film, released three years later, follows Adrianne again — this time as she undergoes 5-MeO-DMT treatment with terminal cancer.

For ibogaine specifically, the first film is the relevant one. It’s shot during her actual treatment session, and unlike many documentaries, it doesn’t cut away from the difficult moments. Adrianne’s experience on camera includes disorientation, physical illness, and emotional distress alongside the reported insights that characterize ibogaine’s action.

What the film gets right: it doesn’t present ibogaine as a clean, cinematic breakthrough. The experience itself looks hard. And the follow-up months later shows the nuance — some things changed, some things didn’t, and the work of integration was ongoing.

What to watch for critically: the film was produced with access to and support from the treatment community, which gives it a warm framing. Questions a patient should ask — about cardiac screening, about what protocols were in place — aren’t addressed in depth.

Where to find it: both films are available on Vimeo on Demand and have been distributed on various streaming platforms. Search by title.

Ayahuasca-Adjacent Films Worth Knowing

The Last Shaman (2016, Netflix)

This film doesn’t feature ibogaine at all — it follows a young American man, James, who travels to the Amazon to work with an ayahuasca shaman after conventional psychiatry fails to resolve his severe depression. It’s included here because it’s frequently cited alongside ibogaine films in the same conversation about plant medicine and Western medical refugees.

If you’ve already seen The Last Shaman and are now researching ibogaine, the conceptual overlap is real: both involve long, difficult psychedelic experiences in a non-Western ceremonial context, both involve people who’ve exhausted conventional treatment, and both raise questions about what medicine means and who gets to administer it.

The film’s relevance to ibogaine is more contextual than direct. It helped mainstream the idea that seriously ill people were traveling internationally for psychedelic treatment — a context that made ibogaine documentaries easier to distribute.

Where to find it: Netflix.

Journalism That Functions Like Documentary

VICE and Motherboard Coverage

Over the past fifteen years, VICE and its Motherboard channel have produced several video segments on ibogaine. These range from short news pieces (5-10 minutes) covering individual treatment stories to longer reported features on the clinic landscape in Mexico, the Bwiti ceremony in Gabon, and the politics of Schedule I. The production quality and journalistic rigor varies considerably.

What these segments collectively document: the explosion of Mexican ibogaine clinics after the late 1990s, the experiences of American veterans seeking treatment south of the border, and the human stories that peer-reviewed papers necessarily omit.

Search ibogaine VICE on YouTube to surface the most widely watched segments. Several have millions of views.

The Joe Rogan Experience

Multiple episodes of the Joe Rogan Experience have featured guests who discuss ibogaine in depth — including veterans and researchers from the Stanford ibogaine study. These conversations aren’t documentaries in the traditional sense, but for ibogaine’s public awareness in the United States, the JRE has been as influential as any film. Episodes with special operations veterans discussing ibogaine treatment in Mexico reached audiences of five to ten million listeners each.

The limitation of podcast coverage: it’s largely first-person testimony from people who had positive outcomes. People who had neutral or negative experiences are underrepresented, and the medical safety context is often thin.

Print Journalism

Several major publications have run long-form reported features on ibogaine worth reading alongside the films. The New Yorker has published extended pieces on psychedelic medicine broadly, with ibogaine-specific coverage of the veteran treatment landscape and the Stanford research. The New York Times ran reporting on the 2024 Stanford study (published in Nature Medicine in 2024) that reached a mass audience unfamiliar with ibogaine. The Washington Post covered the Trump executive order directing VA and DoD research into psychedelic therapies including ibogaine.

These aren’t films, but if you’ve watched one of the documentaries above and want the scientific and policy layer on top of the human story, this journalism is the natural next step.

What the Films Collectively Miss

No major ibogaine documentary to date has given sustained attention to the cardiac safety picture. Ibogaine can prolong the QT interval in a way that creates genuine cardiac risk, particularly in people with pre-existing cardiac conditions or who are taking certain medications. The deaths that have occurred in ibogaine treatment settings — a small but real number — are almost entirely attributable to inadequate screening or monitoring, not to ibogaine itself in appropriate candidates. None of the films above walk a viewer through what a safe screening protocol actually looks like. That’s a significant gap.

Long-term outcomes data is also absent. The films tend to follow people for weeks or months. The research questions that matter most — what percentage of people maintain abstinence or sustained improvement at 12 months, at 24 months — don’t make for good cinema.

The integration period is similarly underrepresented. The treatment session is cinematically compelling. The months of psychological work that follow, which most experienced providers consider essential to durability, rarely get screen time.

From Film to Actual Treatment

If a documentary has brought you to the point of seriously considering ibogaine, the next step isn’t another film. It’s a conversation with someone who can assess whether ibogaine is appropriate for your specific situation.

Psychedelic Connect is a treatment advisory service. We don’t charge patients anything to use our service. We work with a vetted network of ibogaine providers — medical clinics and hybrid retreat models — and we connect people with vetted providers based on their specific condition, medical history, budget, and timeline.

Read the ibogaine safety guide before your first consultation call — it covers the cardiac screening requirements, medication interactions, and contraindications that no documentary will walk you through.

Ready to talk? Schedule a consultation or call (866) 435-7057.

Medical Disclaimer: The content on this page is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified physician before pursuing ibogaine treatment. Individual results vary.